Spots Global Cancer Trial Database for Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
Official Title: Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
Study ID: NCT01457196
Conditions
Interventions
Study Description
Brief Summary: The primary objective of this specimen correlative study is two-fold: to provide a mechanism for the association of known molecular alterations with clinical outcomes, and to provide rapid genetic profiling of alterations with known clinical utility using tumor and germline specimens to support treatment decisions.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Contact Details
Name: H. Shelton Earp, MD
Affiliation: University of North Carolina, Chapel Hill
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
